Journal of Peking University (Health Sciences) ›› 2026, Vol. 58 ›› Issue (2): 388-392. doi: 10.19723/j.issn.1671-167X.2026.02.025

Previous Articles     Next Articles

Outcomes of suture-mediated vascular closure device in the closure of left brachial artery access site after thoracic endovascular aortic repair

Weihao LI, Xuemin ZHANG*(), Wei LI, Tao ZHANG, Xiaoming ZHANG   

  1. Department of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China
  • Received:2023-09-06 Online:2026-04-18 Published:2025-07-25
  • Contact: Xuemin ZHANG
  • Supported by:
    the Beijing Xicheng District Science and Technology Special Projects(XCSTS-SD2022-05)

RICH HTML

  

Abstract:

Objective: To evaluate the feasibility and safety of the suture-mediated vascular closure device in the closure of the left brachial artery access site after thoracic endovascular aortic repair (TEVAR). Methods: Data from 91 patients receiving TEVAR with left brachial artery puncture from January 2021 to May 2023 were retrospectively collected and analyzed. In 27 cases whose brachial artery was over 5 mm, a suture-mediate vascular closure device (Perclose ProGlide, Abbott) was used to deal with the left brachial artery access, and in the other 64 cases with brachial artery < 5 mm, manual compression was used. The primary outcomes were the incidence of perioperative access-related complications and long-term outcomes. Results: In the suture-mediate device group, the access-site compression time was significantly reduced than that in the manual compression group (P < 0.001). The proportion of discomforts, such as numbness, pain, and swelling of the compression-related limbs was significantly lower than that in the compression-alone group (3.70% vs. 42.19%, P < 0.001). One case with brachial artery access-related complications occurred in the suture-mediate device group during hospitalization, which was acute brachial artery occlusion and required reinterventions. In the manual compression group, 4 cases of brachial artery puncture point complications occurred during hospitalization, including 3 cases of pure hematoma with conservative management and 1 case of pseudoaneurysm requiring reintervention. There was no significant difference in the incidence of early puncture point complications between the two groups (3.70% vs. 6.25%, P=0.625). During an average follow-up of (14±6) months, no access-related complications of the left brachial artery occurred. Conclusion: It is effective to use the suture-mediated vascular closure in the left brachial artery access site after TEVAR, and the long-term effect is satisfactory. For patients with >5 mm brachial artery, it is reasonable to use suture-mediated vascular devices to deal with brachial artery access.

Key words: Vascular closure device, Thoracic endovascular aortic repair, Brachial artery, Treatment outcome

CLC Number: 

  • R654.3

Table 1

Comparison of basic data between two groups"

Items Suture-mediate device group (n=27) Compression-alone group (n=64) Statistic P
Gender (male) 22 (81.48) 53 (82.81) >0.999a
Age/years 47.3±13.6 54.2±13.2 -2.255 0.027
BMI/(kg/m2) 24.2±3.6 26.5±5.7 -1.071 0.287
Smoking history 12 (44.44) 30 (46.88) 0.045a 0.832
Hypertension 19 (70.37) 53 (82.81) 1.779a 0.182
Diabetes 2 (7.41) 5 (7.81) >0.999a
Coronary heart disease 2 (7.41) 8 (12.50) 0.732a
Peripheral arterial disease 0 (0) 3 (4.69) 0.552a
ASA grade 0.941a
  Ⅰ 1 (3.70) 5 (7.81)
  Ⅱ 13 (48.15) 26 (40.62)
  Ⅲ 11 (40.74) 27 (42.19)
  Ⅳ 2 (7.41) 6 (9.38)

Figure 1

Suture steps for suture-mediated vascular closure device A, the diameter of brachial artery measured by angiography was 6.48 mm; B, push the vascular closure device forward gently until pulsatile blood spray appears in the observation hole, then stop the advancement and keep the device in place (pay attention to observation hole); C, complete the plunger depression and remove the device while pulling tension on the blue Prolene; D, tighten the vascular suture knot and observe the bleeding in the puncture site; E, after the suture procedure was completed, the bleeding at the puncture point stopped."

Table 2

Comparison of brachial artery compression results between the two groups"

Items Suture-mediate device group (n=27) Compression-alone group (n=64) Statistic P
Brachial artery diameter/mm 5.4±0.3 4.2±0.4 14.7 <0.001
Vascular sheath 0.077a
  5F 0 (0) 5 (7.81)
  6F 19 (70.37) 52 (81.25)
  7F 6 (22.22) 7 (10.94)
  8F 2 (7.41) 0 (0)
Compression time/h 6 (6, 7) 22 (20, 25) -7.537b <0.001b
Oppression-related discomfort 1 (3.70) 27 (42.19) <0.001a
Puncture point complication 1 (3.70) 4 (6.25) 0.625a
  Thrombopoiesis 1 (3.70) 0 (0)
  Hematoma/pseudoaneurysm 0 (0) 4 (6.25)
1
Mandigers TJ , Lomazzi C , Domanin M , et al. Vascular access challenges in thoracic endovascular aortic repair: A literature review[J]. Ann Vasc Surg, 2023, 94, 22- 31.

doi: 10.1016/j.avsg.2022.10.001
2
Noori VJ , Eldrup-Jørgensen J . A systematic review of vascular closure devices for femoral artery puncture sites[J]. J Vasc Surg, 2018, 68 (3): 887- 899.

doi: 10.1016/j.jvs.2018.05.019
3
Dunn K , Jessula S , Herman CR , et al. Safety and effectiveness of single ProGlide vascular access in patients undergoing endovascular aneurysm repair[J]. J Vasc Surg, 2020, 72 (6): 1946- 1951.

doi: 10.1016/j.jvs.2020.03.028
4
孙占国, 蒋京军, 张小明, 等. TEVER术中主动脉弓部分支动脉的重建[J]. 中国普通外科杂志, 2014, 23 (12): 1609- 1613.
5
佟铸, 谷涌泉, 郭连瑞, 等. 肱动脉入路在腔内治疗中的应用及穿刺并发症分析[J]. 中国微创外科杂志, 2012, 12 (6): 547-549, 553.
6
王汝涛, 戴一, 刘毅, 等. 冠脉造影术中肱动脉穿刺的常见并发症及处理[J]. 临床医学研究与实践, 2017, 2 (32): 115-116, 123.
7
徐彦成, 刘祎秀. 肱动脉穿刺在经皮冠状动脉介入治疗术后并发症的预防及处理研究[J]. 中西医结合心血管病电子杂志, 2018, 6 (9): 82-83, 86.
8
史作霞, 张文彦, 李馨, 等. 改良桡动脉止血器在老年ACS患者动脉穿刺后压迫止血中的效果[J]. 医学信息, 2020, 33 (2): 184- 185.
9
刘玉龙, 李承志, 王晓白, 等. ExoSeal血管封堵器在肱动脉高位穿刺点止血中的临床应用[J]. 介入放射学杂志, 2020, 29 (6): 560- 563.
10
Meertens MM , de Haan MW , Schurink GWH , et al. A stopped pilot study of the ProGlide closure device after transbrachial endovascular interventions[J]. J Endovasc Ther, 2019, 26 (5): 727- 731.

doi: 10.1177/1526602819862775
[1] Youdong LIU, Yajun LYU, Jie CHEN, Mingde ZANG, Hongda PAN, Xiaowen LIU, Jun LU, Fenglin LIU. Clinical efficacy and safety of totally laparoscopic subtotal gastrectomy with cardia-gastric fundus preservation in middle-upper gastric cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 301-306.
[2] Ebrahimi Farin, Zhiqiang FENG, Ebrahimi Faraz, Weihua HAN, Ziyang YU, Kuankuan JIA, Jingang AN. Surgical treatment outcomes of different stages of maxillary medication-related osteonecrosis of the jaw [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 107-114.
[3] Lianfei PAN, Wenjing LI, Ruiyang WANG, Jian JIAO, Zhanqiang CAO, Li GAO, Dong SHI. Short-term efficacy and influencing factors of systemic antibiotics as an adjunct to mechanical periodontal therapy for stages Ⅲ/Ⅳ periodontitis [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 30-36.
[4] Yuanyuan YANG, Shanshan ZHANG, Guangyan YU, Huijun YANG, Hongyu YANG. Clinical outcomes of partial sialoadenectomy for the treatment of benign tumors in the submandibular gland [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 334-339.
[5] Yifan KANG, Yanjun GE, Xiaoming LV, Shang XIE, Xiaofeng SHAN, Zhigang CAI. One-stage mandibular reconstruction combining iliac flap with immediate implant-based denture [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 78-84.
[6] Wenjing LI,Baozhou ZHANG,Heng LI,Liangpeng LAI,Hui DU,Ning SUN,Xiaofeng GONG,Ying LI,Yan WANG,Yong WU. Tibiotalocalcaneal arthrodesis for end-stage ankle and hindfoot arthropathy: Short- and mid-term clinical outcomes [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 299-306.
[7] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[8] Min QIU,You-long ZONG,Bin-shuai WANG,Bin YANG,Chu-xiao XU,Zheng-hui SUN,Min LU,Lei ZHAO,Jian LU,Cheng LIU,Xiao-jun TIAN,Lu-lin MA. Treatment outcome of laparoscopic partial nephrectomy in patients with renal tumors of moderate to high complexity [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 833-837.
[9] Lei WANG,Tian-dong HAN,Wei-xing JIANG,Jun LI,Dao-xin ZHANG,Ye TIAN. Comparison of safety and effectiveness of active migration technique and in situ lithotripsy technique in the treatment of 1-2 cm upper ureteral calculi by flexible ure-teroscopy [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 553-557.
[10] LI Wei-hao,LI Wei,ZHANG Xue-min,LI Qing-le,JIAO Yang,ZHANG Tao,JIANG Jing-jun,ZHANG Xiao-ming. Comparison of the outcomes between open and hybrid approaches in the treatment of thoracoabdominal aortic aneurysms repair [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 177-181.
[11] Yan-fang JIANG,Jian WANG,Yong-jian WANG,Jia LIU,Yin PEI,Xiao-peng LIU,Ying-fang AO,Yong MA. Mid-to-long term clinical outcomes and predictors after anterior cruciate ligament revision [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 857-863.
[12] Zheng-da ZHU,Yan GAO,Wen-xiu HE,Xin FANG,Yang LIU,Pan WEI,Zhi-min YAN,Hong HUA. Efficacy and safety of Nocardia rubra cell wall skeleton for the treatment of erosive oral lichen planus [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 964-969.
[13] Xiao LI,Jia-zeng SU,Yan-yan ZHANG,Li-qi ZHANG,Ya-qiong ZHANG,Deng-gao LIU,Guang-yan YU. Inflammation grading and sialoendoscopic treatment of131I radioiodine-induced sialadenitis [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 586-590.
[14] Ying ZHAN,Yi-tian DU,Zhen-zhen YANG,Chun-li ZHANG,Xian-rong QI. Preparation and characterization of paclitaxel microspheres in situ gel and its antitumor efficacy by local injection [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 477-486.
[15] Ze-chuan YANG,Chao-xu LIU,Yang LIN,Wei-hua HU,Wen-jian CHEN,Feng LI,Heng ZENG. All levels miniplate fixation and a modified hybrid fixation method in expansive open-door cervical laminoplasty: a retrospective comparative study [J]. Journal of Peking University(Health Sciences), 2019, 51(1): 187-193.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!